Document
type: Class

Continuant
type: Class

Entity
type: Class

Generically Dependent Continuant
type: Class

165633
type: Relationship
type: BFO_0000020
type: Entity
type: Thing
type: Grant
type: Continuant
funding vehicle for: Chemotherapy pro-drug activation by biocatalytic virus-like nanoparticles containing cytochrome P450

RDF description of Chemotherapy pro-drug activation by biocatalytic virus-like nanoparticles containing cytochrome P450 - http://orbis.uaslp.mx/vivo/individual/scopus3970
rights: termsOfUse
date: 2026-08-27T05:46:22
publisher: vivo
type: Document

Article
type: Class

Chemotherapy pro-drug activation by biocatalytic virus-like nanoparticles containing cytochrome P450
e iscopus: 2-s2.0-84899829587
volume: 60
related by: authorship_23101
related by: authorship_23103
type: Information Content Entity
has funding vehicle: 165633
type: Continuant
doi: 10.1016/j.enzmictec.2014.04.003
most specific type: Document
abstract: This work shows, for the first time, the encapsulation of a highly relevant protein in the biomedical field into virus-like particles (VLPs). A bacterial CYP variant was effectively encapsulated in VLPs constituted of coat protein from cowpea chlorotic mottle virus (CCMV). The catalytic VLPs are able to transform the chemotherapeutic pro-drug, tamoxifen, and the emerging pro-drug resveratrol. The chemical nature of the products was identified, confirming similar active products than those obtained with human CYP. The enzymatic VLPs remain stable after the catalytic reaction. The potential use of these biocatalytic nanoparticles as targeted CYP carriers for the activation of chemotherapy drugs is discussed. © 2014 Elsevier Inc.
type: Entity
type: Generically Dependent Continuant
freetext keyword: Bionanotechnology; Catalytic VLPs; CYP; Resveratrol; Tamoxifen Catalysis; Catalyst activity; Chemotherapy; Nanoparticles; Proteins; Resveratrol; Biomedical fields; Bionanotechnology; Catalytic reactions; Catalytic VLPs; Cowpea chlorotic mottle virus; CYP; Tamoxifen; Virus-like particles; Viruses; 3,4' dihydroxytamoxifen; afimoxifene; antineoplastic agent; coat protein; cyclophosphamide; cytochrome P450; dacarbazine; endoxifen; hydrogen peroxide; ifosfamide; isopropyl thiogalactoside; n demethylase; nanocarrier; nortamoxifen; pentoxyresorufin; prodrug; resveratrol; syringol; tamoxifen; tegafur; unclassified drug; antineoplastic agent; bacterial protein; capsid protein; cytochrome P450; drug carrier; nanocapsule; nanoparticle; prodrug; resveratrol; stilbene derivative; tamoxifen; article; Bacillus megaterium; biocatalysis; cancer chemotherapy; cowpea chlorotic mottle virus; dealkylation; drug activation; drug delivery system; drug metabolism; drug transformation; encapsulation; enzyme activity; Escherichia coli; nonhuman; plant virus; protein expression; transmission electron microscopy; virus like agent; biocatalysis; Bromovirus; chemistry; drug delivery system; genetics; human; kinetics; metabolic activation; metabolism; ultrastructure; virion; Activation, Metabolic; Antineoplastic Agents; Bacillus megaterium; Bacterial Proteins; Biocatalysis; Bromovirus; Capsid Proteins; Cytochrome P-450 Enzyme System; Drug Carriers; Drug Delivery Systems; Humans; Kinetics; Nanocapsules; Nanoparticles; Prodrugs; Stilbenes; Tamoxifen; Virion
pmid: 24835096
crisid: 3971
type: Article
type: Thing
date time value: article date 3971
type: Document
page start: 24
has publication venue: Enzyme and Microbial Technology
estado: published
most specific type: Article
related by: authorship_23098
related by: authorship_23100
related by: authorship_23102
chemicalscas: afimoxifene, 65213-48-1, 68392-35-8; cyclophosphamide, 50-18-0; cytochrome P450, 9035-51-2; dacarbazine, 4342-03-4; endoxifen, 110025-28-0, 112093-28-4; hydrogen peroxide, 7722-84-1; ifosfamide, 3778-73-2; isopropyl thiogalactoside, 26112-89-0; nortamoxifen, 31750-48-8; pentoxyresorufin, 87687-03-4; resveratrol, 501-36-0; syringol, 91-10-1; tamoxifen, 10540-29-1; tegafur, 17902-23-7; Antineoplastic Agents; Bacterial Proteins; Capsid Proteins; Cytochrome P-450 Enzyme System; Drug Carriers; Nanocapsules; Prodrugs; resveratrol; Stilbenes; Tamoxifen
page end: 31
related by: authorship_23099
origen: scopus
related by: authorship_23104

Information Content Entity
type: Class

Enzyme and Microbial Technology
type: Journal
type: Thing
type: Generically Dependent Continuant
type: Collection
type: Entity
type: Periodical
type: Document
type: Continuant
publication venue for: Chemotherapy pro-drug activation by biocatalytic virus-like nanoparticles containing cytochrome P450
type: Information Content Entity